Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) FCF Margin (2021 - 2025)

Historic FCF Margin for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to 96497.15%.

  • HeartSciences' FCF Margin fell 983539400.0% to 96497.15% in Q4 2025 from the same period last year, while for Oct 2025 it was 2106.22%, marking a year-over-year decrease of 42223900.0%. This contributed to the annual value of 170486.23% for FY2025, which is 1375042900.0% down from last year.
  • Latest data reveals that HeartSciences reported FCF Margin of 96497.15% as of Q4 2025, which was down 983539400.0% from 102808.79% recorded in Q3 2025.
  • HeartSciences' 5-year FCF Margin high stood at 8961.73% for Q3 2024, and its period low was 102808.79% during Q3 2025.
  • Over the past 5 years, HeartSciences' median FCF Margin value was 19870.16% (recorded in 2023), while the average stood at 28962.75%.
  • As far as peak fluctuations go, HeartSciences' FCF Margin soared by 607286500bps in 2023, and later tumbled by -1117705200bps in 2025.
  • HeartSciences' FCF Margin (Quarter) stood at 9587.0% in 2021, then plummeted by -493bps to 56842.34% in 2022, then skyrocketed by 55bps to 25388.18% in 2023, then surged by 107bps to 1856.79% in 2024, then tumbled by -5297bps to 96497.15% in 2025.
  • Its FCF Margin was 96497.15% in Q4 2025, compared to 102808.79% in Q3 2025 and 879.53% in Q2 2025.